×
About 105 results

ALLMedicine™ Pneumocystis Jiroveci Pneumonia (PJP) Center

Research & Reviews  49 results

Critical appraisal of the quality and content of clinical practice guidelines for pneum...
https://doi.org/10.1111/jcpt.13213
Journal of Clinical Pharmacy and Therapeutics REFERENCES; Yu Y, Yang H et. al.

Jul 27th, 2020 - Pneumocystis jiroveci (P jiroveci) is an important opportunistic fungus and causes pneumocystis jiroveci pneumonia (PJP) in kidney transplant recipients (KTRs). By using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument...

Pneumocystis jiroveci.
https://doi.org/10.1055/s-0039-3399559
Seminars in Respiratory and Critical Care Medicine; Fishman JA

Jan 30th, 2020 - Pneumocystis jiroveci remains an important fungal pathogen in a broad range of immunocompromised hosts. The natural reservoir of infection remains unknown. Pneumocystis jiroveci Pneumonia (PJP) develops via airborne transmission or reactivation of...

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
https://www.mdedge.com/chestphysician/article/210199/cll/pjp-prophylaxis-may-be-unnecessary-cll-patients-btk-inhibitors?channel=234
Sharon Worcester, MDedge News

Oct 16th, 2019 - EDINBURGH – Routine empiric prophylaxis against pneumocystis jiroveci pneumonia (PJP) may be unwarranted in chronic lymphocytic leukemia patients initiating Bruton tyrosine kinase (BTK) inhibitor therapy, a retrospective chart review suggests. Dr.

Sulfonamide desensitization in solid organ transplant recipients: A protocol-driven app...
https://doi.org/10.1111/tid.13191
Transplant Infectious Disease : an Official Journal of Th... Pryor JB, Olyaei AJ et. al.

Oct 9th, 2019 - Trimethoprim-sulfamethoxazole (TMP-SMX) is the first-line agent for Pneumocystis jiroveci pneumonia (PJP) prophylaxis for solid organ transplant (SOT) recipients because of its efficacy for this indication, extended antimicrobial coverage, and fav...

Pneumocystis jiroveci Pneumonia (PJP) Overview of Pneumocystis jiroveci Pneumonia
https://emedicine.medscape.com/article/225976-overview

Apr 23rd, 2019 - Overview of Pneumocystis jiroveci Pneumonia Pneumocystis jiroveci pneumonia (PJP), formerly known as Pneumocystis carinii pneumonia (PCP), is the most common opportunistic infection in persons with HIV infection. Pneumocystis first came to attenti...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  53 results

Critical appraisal of the quality and content of clinical practice guidelines for pneum...
https://doi.org/10.1111/jcpt.13213
Journal of Clinical Pharmacy and Therapeutics REFERENCES; Yu Y, Yang H et. al.

Jul 27th, 2020 - Pneumocystis jiroveci (P jiroveci) is an important opportunistic fungus and causes pneumocystis jiroveci pneumonia (PJP) in kidney transplant recipients (KTRs). By using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument...

Pneumocystis jiroveci.
https://doi.org/10.1055/s-0039-3399559
Seminars in Respiratory and Critical Care Medicine; Fishman JA

Jan 30th, 2020 - Pneumocystis jiroveci remains an important fungal pathogen in a broad range of immunocompromised hosts. The natural reservoir of infection remains unknown. Pneumocystis jiroveci Pneumonia (PJP) develops via airborne transmission or reactivation of...

Nebupent - pentamidine isethionate inhalant-Fresenius Kabi USA, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb

Jan 22nd, 2020 - NebuPent is indicated for the prevention of Pneumocystis jiroveci pneumonia (PJP) in high-risk, HIV-infected patients defined by one or both of the following criteria: i. a history of one or more episodes of PJP ii. a peripheral CD4+ (T4 helper/in...

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
https://www.mdedge.com/chestphysician/article/210199/cll/pjp-prophylaxis-may-be-unnecessary-cll-patients-btk-inhibitors?channel=234
Sharon Worcester, MDedge News

Oct 16th, 2019 - EDINBURGH – Routine empiric prophylaxis against pneumocystis jiroveci pneumonia (PJP) may be unwarranted in chronic lymphocytic leukemia patients initiating Bruton tyrosine kinase (BTK) inhibitor therapy, a retrospective chart review suggests. Dr.

Pentamidine isethionate - pentamidine isethionate inhalant-Seton Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c484f16e-9d97-4416-84a4-8ad8deaf5e19

Oct 10th, 2019 - Pentamidine Isethionate is indicated for the prevention of Pneumocystis jiroveci pneumonia (PJP) in high-risk, HIV-infected patients defined by one or both of the following criteria: i. a history of one or more episodes of PJP ii. a peripheral CD4...

see more →

News  1 results

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
https://www.mdedge.com/chestphysician/article/210199/cll/pjp-prophylaxis-may-be-unnecessary-cll-patients-btk-inhibitors?channel=234
Sharon Worcester, MDedge News

Oct 16th, 2019 - EDINBURGH – Routine empiric prophylaxis against pneumocystis jiroveci pneumonia (PJP) may be unwarranted in chronic lymphocytic leukemia patients initiating Bruton tyrosine kinase (BTK) inhibitor therapy, a retrospective chart review suggests. Dr.

see more →